argenx SE
ARGXNASDAQHealthcare● Active
$882.41
$-8.91(-1.00%)
Market Cap$54.6B
P/E Ratio—
52W High$934.62
52W Low$510.055
argenx SE（ARGX）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ARGX · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.30B | $0.83B | ($0.43B) | ($0.72B) | ($0.35B) |
| Depreciation & Amort. | $0.00B | $0.02B | $0.11B | $0.10B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.24B | $0.23B | $0.16B | $0.18B |
| Change in Working Capital | ($0.42B) | ($0.32B) | ($0.31B) | ($0.38B) | ($0.34B) |
| Net Cash from Operations | $0.85B | ($0.08B) | ($0.42B) | ($0.86B) | ($0.61B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.07B) | ($0.04B) | ($0.10B) | ($0.12B) |
| Purchases of Investments | ($1.46B) | ($2.18B) | ($1.27B) | ($1.69B) | ($0.23B) |
| Sales of Investments | $2.40B | $1.43B | $1.54B | $1.33B | $0.00B |
| Net Cash from Investing | $0.82B | ($0.72B) | $0.31B | ($0.46B) | ($0.35B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | $0.23B | $0.28B | $1.34B | $0.84B | $1.12B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.84B | ($0.15B) | ($0.46B) | ($0.97B) | ($0.73B) |
| FCF Margin %(computed) | 20.33% | -6.90% | -37.85% | -235.33% | -146.45% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解argenx SE
关于argenx SE（ARGX）现金流量表
argenx SE 2025财年经营活动现金流$0.85B，自由现金流$0.84B（FCF利润率20.33%），资本支出($0.01B)。
常见问题
ARGX · 4 问argenx SE 2025财年自由现金流$0.84B，同比up659.0%。
ARGX free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10